# Nimble Rx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nimble-rx

- Industry: Consumer Services
- Headquarters: Menlo Park, US
- Website: www.nimblerx.com
- Total disclosed funding: $28M
- Latest round: Series A (Oct 24, 2017)
- Investors on record: 5

## About

NimbleRx provides pharmacy and prescription management solutions focused on enhancing patient engagement and streamlining pharmacy operations through a digital ordering platform and innovative revenue-generating programs.Founded in 2014 and headquartered in Menlo Park, US, NimbleRx specializes in pharmacy management solutions. The company has adapted its business strategy to focus on digital ordering and partnerships with life science companies. CEO Talha Sattar has previously founded other companies, supporting NimbleRx's operations. The firm raised USD 14.75 mn in its Series E round on May 31, 2022, valuing the company at USD 1.3 bn post-money.NimbleRx specializes in pharmacy and prescription management solutions designed to enhance patient engagement and streamline pharmacy operations. Their core offerings include an integrated digital ordering platform that facilitates effortless online ordering for patients, ensuring a seamless experience that supports adherence to prescribed medications. The company optimizes pharmacy workflows to enhance productivity and operational efficiency. NimbleRx also provides innovative programs aimed at generating new revenue streams for independent pharmacies by leveraging partnerships with leading life science companies, serving independent pharmacies and healthcare providers across the United States.NimbleRx generates revenue through partnerships and integrated service offerings for independent pharmacies. The company operates on a transactional model where pharmacies utilize its digital ordering solutions and marketing strategies to foster patient retention and improve health outcomes. Subscription agreements allow pharmacies to access Nimble's services, including performance marketing tools and revenue-generating programs. The company's flagship offerings are designed to enhance pharmacies’ operational capabilities and financial performance through targeted marketing and real-time analytics, thus supporting clients in maximizing patient satisfaction and revenue generation.NimbleRx is focused on launching new products and expanding into additional markets. The recent Series E funding of USD 14.75 mn will support these initiatives. In May 2022, the company raised financing to enhance its platform and services. The firm aims to broaden its reach, targeting new geographic regions to better serve independent pharmacies and healthcare providers. Recent funding will facilitate further development of digital solutions and marketing programs that align with these growth strategies.

## Funding rounds

- Series A, Oct 24, 2017, $28M — Hong Shan, DAG Ventures, Khosla Ventures, First Round Capital, Y Combinator

## Investors

- Hong Shan — Series A
- DAG Ventures (https://capitalatlas.ai/funds/dag-ventures) — Series A
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- First Round Capital (https://capitalatlas.ai/funds/first-round-capital) — Series A
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Series A